68 Ga-FAPI-46 and 18 F-FDG in Advanced Metastatic Pancreatic Cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 35714370.
- Also identified by DOI 10.1097/RLU.0000000000004316.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recently imaging with new PET radiotracers that act as fibroblast activation protein inhibitors (FAPIs) showed promising results in oncology and even nononcology imaging. Here we report a case of advanced pancreatic adenocarcinoma, imaged with both 18 F-FDG and 68 Ga-FAPI-46 PET/CT scans. The result indicated that imaging with 68 Ga-FAPI-46 showed significant improvement in detection of metastases as well as local malignancy recurrence. Moreover, the intensity and SUVs of the lesions were higher in 68 Ga-FAPI-46 scan compared with 18 F-FDG.
Medical subject headings
- Adenocarcinoma
- Pancreatic Neoplasms